HOME >> MEDICINE >> NEWS
UK and other European countries should introduce universal childhood hepatitis B vaccination

most effective means of reducing the global burden of a particular disease. It also protects children before they are at risk of infection, and vaccines available today can immunise individuals for life with no need for additional booster vaccinations. Disadvantages include cost-effectiveness in countries of low endemicity and concerns about adding another vaccine into the childhood vaccination programme.

The advantages of the at-risk strategy are that an immediate impact within the target group can be obtained, with low cost in countries with low endemicity. Disadvantages include leaving the general population at risk, the difficulties in properly identifying at risk groups and the social stigma of being defined at-risk.

The authors conclude that on the basis of current experience and evidence, the UK, Ireland, Finland, Iceland, the Netherlands, Norway, Sweden, and Denmark should all adopt a universal vaccination policy.

They say: Global hepatitis B universal vaccination is ultimately the only way to eliminate HBV transmission and new cases of hepatitis B. Indeed, global efforts to control and prevent hepatitis B are of crucial importance and it is the responsibility of each country worldwide to play its part.


'"/>

Contact: Dr. Jane Zuckerman
j.zuckerman@medsch.ucl.ac.uk
44-779-887-6445
Lancet
5-Jun-2007


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
5. Chemotherapy may enhance the effectiveness of brain tumor vaccines
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Adding radioimmunotherapy to chemo may help patients with lymphoma
8. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
9. Medical management of another condition may not lead to early cancer diagnosis
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. New mothers often not asked about depression, UNC survey finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Healthy eating isn’t always easy. Currently, more than 80 percent of ... many Americans overeat refined grains and sugar. This trend may help explain why the obesity ... U.S. are obese. , As a culture, we seem to have food on the brain ...
(Date:7/27/2017)... ... 27, 2017 , ... HIMSS announced today that Michael Daniel, ... the HIMSS Healthcare Security Forum, the nation’s foremost event for health organizations tackling ... 2017. , Daniel will deliver his keynote, The Evolving Healthcare Information Security Organization, ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... Management Solutions as part of their continued efforts to provide innovative offerings to ... the best IT resources and build dynamic, high-performing teams to address healthcare IT’s ...
(Date:7/26/2017)... ... 27, 2017 , ... It's time to sign up for the new One-A-Month Essential ... Kathy Heshelow, founder of Sublime Naturals and author of numerous books on essential oils. , ... mailed by the 5th. , Two items are included in the December ...
(Date:7/26/2017)... Oak, Michigan (PRWEB) , ... July 26, 2017 , ... ... newly appointed Medical Director for the treatment program located in Royal Oak, Michigan. ... group of investors who are focused on providing the highest standards in the field ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017  IBM ... of Alberta in Edmonton, Canada ... journal, Schizophrenia 1 , demonstrating that AI and ... with 74% accuracy. This retrospective analysis also showed ... in schizophrenia patients with significant correlation, based on ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... International plc (NASDAQ: ENDP ) will announce its second-quarter ... senior management team will host a conference call and webcast before ... The dial-in number to access the call is U.S./ ... is 45397076. Please dial in 10 minutes prior to the scheduled ... of the call will be available from August 8, 2017 at ...
Breaking Medicine Technology:
Cached News: